OPR - Delayed Quote • USD ABCL Oct 2024 6.000 call (ABCL241018C00006000) Follow 0.2500 0.0000 (0.00%) At close: April 24 at 3:38 PM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for ABCL241018C00006000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: ABCL AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024 The 7 Best Penny Stocks to Buy in Q2 2024 Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024 AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024 After losing 38% in the past year, AbCellera Biologics Inc. (NASDAQ:ABCL) institutional owners must be relieved by the recent gain 3 Highly Rated Biotech Stocks to Buy for 300% Gains AbCellera Announces Resignation of Board Member AbCellera to Present at Upcoming Investor Conferences in March AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript
